OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
“Stabilise-reduce, stabilise-reduce”: A survey of the common practices of deprescribing services and recommendations for future services
Ruth Cooper, Michael Ashman, Jo Lomani, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282988-e0282988
Open Access | Times Cited: 9
Ruth Cooper, Michael Ashman, Jo Lomani, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282988-e0282988
Open Access | Times Cited: 9
Showing 9 citing articles:
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles
Mark Horowitz, Joanna Moncrieff
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 320-330
Open Access | Times Cited: 7
Mark Horowitz, Joanna Moncrieff
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 320-330
Open Access | Times Cited: 7
Designing withdrawal support services for antidepressant users: Patients’ views on existing services and what they really need
John Read, Joanna Moncrieff, Mark Horowitz
Journal of Psychiatric Research (2023) Vol. 161, pp. 298-306
Open Access | Times Cited: 14
John Read, Joanna Moncrieff, Mark Horowitz
Journal of Psychiatric Research (2023) Vol. 161, pp. 298-306
Open Access | Times Cited: 14
The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS)
Joanna Moncrieff, John Read, Mark Horowitz
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100765-100765
Open Access | Times Cited: 4
Joanna Moncrieff, John Read, Mark Horowitz
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100765-100765
Open Access | Times Cited: 4
Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services
Mark Horowitz, Joshua E. J. Buckman, Rob Saunders, et al.
Psychiatry Research (2025), pp. 116497-116497
Closed Access
Mark Horowitz, Joshua E. J. Buckman, Rob Saunders, et al.
Psychiatry Research (2025), pp. 116497-116497
Closed Access
Using in silico methods to determine optimal tapering regimens for decanoate-based long-acting injectable psychosis drugs
James R. O’Neill, David Taylor, Mark Horowitz
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 2
James R. O’Neill, David Taylor, Mark Horowitz
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 2
‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use
Thomas R. Lynch, Cristín Ryan, Christy Huff, et al.
Health Expectations (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Thomas R. Lynch, Cristín Ryan, Christy Huff, et al.
Health Expectations (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
